US$ 25.69
could glp-1 be the next mental health drug New study confirms medications are safe for in diabetes GLP-1 Medications and Mental Health:
Description
Moreover, the reduced splanchnic blood flow could affect nutrient uptake or affect digestion (107) leads to uncertainty regarding effects on memory and cognitive functions

In a phase 2 clinical trial, CagriSema reduced HbA1c by 2.2% (p = 0.075) in comparison with semaglutide 2.4 mg alone [101]

In the context of MASLD/MASH, analogous rebound phenomena would be expected: regression of achieved steatosis resolution and potential re-emergence of inflammatory activity and fibrogenic stimuli upon drug withdrawal

The value of serum adiponectin in osteoporotic women: does weight have an effect
